Trials / Sponsors / Shanghai Longwood Biopharmaceuticals Co., Ltd.
Shanghai Longwood Biopharmaceuticals Co., Ltd.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Sev Moderate to Severe Atopic Dermatitis | Phase 3 | 2026-01-30 |
| Recruiting | Study of LW231 in Participants With Chronic Hepatitis B Chronic HBV Infection | Phase 1 / Phase 2 | 2025-10-01 |
| Completed | Study of LW402 in Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis (AD) | Phase 2 | 2023-05-11 |
| Completed | Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 2 | 2023-02-27 |
| Completed | A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers Chronic Hepatitis B | Phase 1 | 2022-06-21 |